Jun 01, 2026

Revolution Medicines (RVMD) Stock Soars 20% on Breakthrough Pancreatic Cancer Tr...

Revolution Medicines (RVMD) stock jumped 20% after daraxonrasib doubled pancreatic cancer survival to 13.2 months in Phase 3 trial...

Jun 01, 2026

Strategy sells 32 BTC in first Bitcoin sale since 2022

The world's largest public Bitcoin holder reduced its stash to 843,706 BTC, while raising $128.3 million through Class A stock sal...

Jun 01, 2026

CoreWeave (CRWV) Stock Rallies 6% on Triple Announcement Wave

CoreWeave (CRWV) stock rose 6.5% pre-market on Tensormesh investment, Russell 3000 Index addition, and deployment of Nvidia's Vera...

Jun 01, 2026

Tech Momentum Drives Stock Futures Higher as June Trading Begins Following Stell...

Stock futures climb Monday extending May's tech rally. Nasdaq surged 8% last month. Iran conflict and Friday's jobs report weigh o...

Jun 01, 2026

Japan's ruling party supports crypto ETF trading, yen-based stablecoins

Japan's ruling Liberal Democratic Party said the country should create a legal framework for trading crypto ETFs in a proposal to...

Jun 01, 2026

Bitmine (BMNR) Stock: Ethereum Stake Surpasses $9.5B Valuation Milestone

Bitmine (BMNR) stock faces pre-market pressure as staked Ethereum exceeds $9.5B. Company aims for 5% of total ETH supply by year-e...

Jun 01, 2026

Ethereum ETFs Bled $708m in 14 Straight Days as XRP and Solana Gained

Ethereum Dominance Slumps as ETF Sell-the-News Phase DeepensThe post Ethereum ETFs Bled $708m in 14 Straight Days as XRP and Sola...

Jun 01, 2026

Nebius (NBIS) Stock Surges After Former OpenAI Researcher Acquires 5.6% Position

Nebius (NBIS) stock rises after Leopold Aschenbrenner's $13.7B hedge fund acquires 5.6% stake. Q1 revenue jumped 684% YoY to $399M...

Jun 01, 2026

Gnosis Pay exploit hits delay module as team pledges refunds

Gnosis Pay faces an active exploit in its delay module as co‑founder Martin Köppelmann walks back a warning urging users to withdr...

Jun 01, 2026

IBM (IBM) Stock Soars 12% Following Barclays Overweight Rating and $350 Target

IBM stock jumped 12% after Barclays initiated coverage at Overweight with a $350 target, emphasizing its enterprise software stren...